SIC
VKTX icon

SJS Investment Consulting’s Viking Therapeutics VKTX Stock Holding History

SJS Investment Consulting’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118 Buy
+3
New +$97 ﹤0.01% 2580

Other funds holding VKTX

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
LA
LBP AM Paris, France $10B AUM 43.88% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
LAM
Lewis Asset Management Lafayette, California $285M AUM 32.52% 1-Year Est. Return

SJS Investment Consulting's VKTX Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 3 shares worth $118. The stake represents ﹤0.01% of the portfolio and ranks #2580 among its holdings.

109 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • SJS Investment Consulting held 3 shares of Viking Therapeutics worth $118 as of Q2 2026.
  • Viking Therapeutics was a new SJS Investment Consulting position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2580 holding.
  • 109 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.